Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Longstreth, W. T.
Right arrow Articles by Weaver, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Longstreth, W. T., Jr
Right arrow Articles by Weaver, W. D.

Stroke, Vol 24, 587-590, Copyright © 1993 by American Heart Association


ARTICLES

Myocardial infarction, thrombolytic therapy, and stroke. A community- based study. The MITI Project Group

WT Longstreth Jr, PE Litwin and WD Weaver
Department of Medicine, University of Washington, Seattle.

BACKGROUND: Thrombolytic therapy used in patients with acute myocardial infarction may increase the risk of stroke. Scant information is available from community-based studies. SUMMARY OF REPORT: Among 5,635 consecutive patients admitted with acute myocardial infarction to hospitals in Seattle and surrounding suburban King County, Washington, 116 (2.1%) experienced strokes during hospitalization. Of these strokes, 82 (71%) were ischemic and 34 (29%) were hemorrhagic, defined by a patient's having had a computed tomographic scan of the head that showed blood. Thrombolytic therapy was given to 1,413 of these patients (25%) and was associated with increased risk of hemorrhagic stroke but reduced risk of ischemic stroke. The relative risk of stroke with thrombolytic therapy was estimate using multiple logistic regression to adjust for potential confounding factors. The adjusted relative risk for hemorrhagic stroke was 3.6 (95% confidence interval [CI], 1.7-8.0); for ischemic stroke, 0.4 (95% CI, 0.2-0.9); and for overall stroke, 1.0 (95% CI, 0.6-1.7). The adjusted risk for death from any cause following stroke was 3.0 (95% CI, 1.4-6.4). CONCLUSIONS: Although thrombolytic therapy had little effect on the overall occurrence of stroke, thrombolytic therapy increased the risk of stroke death because more patients with hemorrhagic than ischemic strokes died during their hospitalization. The rates of hemorrhagic stroke with thrombolytic therapy reported in the present study are higher than those reported in clinical trials in which treatment is given to select patients under strict protocols.


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
B. J. Witt, R. D. Brown Jr., S. J. Jacobsen, S. A. Weston, B. P. Yawn, and V. L. Roger
A Community-Based Study of Stroke Incidence after Myocardial Infarction
Ann Intern Med, December 6, 2005; 143(11): 785 - 792.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Budaj, K. Flasinska, J. M. Gore, F. A. Anderson Jr, O. H. Dabbous, F. A. Spencer, R. J. Goldberg, K. A.A. Fox, and for the GRACE Investigators
Magnitude of and Risk Factors for In-Hospital and Postdischarge Stroke in Patients With Acute Coronary Syndromes: Findings From a Global Registry of Acute Coronary Events
Circulation, June 21, 2005; 111(24): 3242 - 3247.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Savonitto, P.W. Armstrong, A.M. Lincoff, G. Jia, C.A. Sila, J. Booth, P. Terrosu, C. Cavallini, H.D. White, D. Ardissino, et al.
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction: Dichotomous response as a function of age in the GUSTO V trial
Eur. Heart J., October 2, 2003; 24(20): 1807 - 1814.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Cronin, S. R. Mehta, F. Zhao, J. Pogue, A. Budaj, D. Hunt, and S. Yusuf
Stroke in Relation to Cardiac Procedures in Patients With Non-ST-Elevation Acute Coronary Syndrome: A Study Involving >18 000 Patients
Circulation, July 17, 2001; 104(3): 269 - 274.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. M. Akkerhuis, J. W. Deckers, A. M. Lincoff, J. E. Tcheng, E. Boersma, K. Anderson, C. Balog, R. M. Califf, E. J. Topol, and M. L. Simoons
Risk of Stroke Associated With Abciximab Among Patients Undergoing Percutaneous Coronary Intervention
JAMA, July 4, 2001; 286(1): 78 - 82.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. W. Mahaffey, R. A. Harrington, M. L. Simoons, C. B. Granger, C. Graffagnino, M. J. Alberts, D. T. Laskowitz, J. M. Miller, M. A. Sloan, L. G. Berdan, et al.
Stroke in Patients With Acute Coronary Syndromes : Incidence and Outcomes in the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial
Circulation, May 11, 1999; 99(18): 2371 - 2377.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. Tanne, S. Gottlieb, A. Caspi, H. Hod, A. Palant, L. Reisin, T. Rosenfeld, B. Peled, A. T. Marmor, J. Balkin, et al.
Treatment and Outcome of Patients With Acute Myocardial Infarction and Prior Cerebrovascular Events in the Thrombolytic Era: The Israeli Thrombolytic National Survey
Arch Intern Med, March 23, 1998; 158(6): 601 - 606.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. W. Mahaffey, C. B. Granger, M. A. Sloan, T. D. Thompson, J. M. Gore, W. D. Weaver, H. D. White, M. L. Simoons, G. I. Barbash, E. J. Topol, et al.
Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis : Results From GUSTO-I
Circulation, March 3, 1998; 97(8): 757 - 764.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. M. Gebel, C. A. Sila, M. A. Sloan, C. B. Granger, K. W. Mahaffey, J. Weisenberger, C. L. Green, H. D. White, J. M. Gore, W. D. Weaver, et al.
Thrombolysis-Related Intracranial Hemorrhage : A Radiographic Analysis of 244 Cases From the GUSTO-1 Trial With Clinical Correlation
Stroke, March 1, 1998; 29(3): 563 - 569.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. A. Sloan, T. R. Price, M. L. Terrin, S. Forman, J. M. Gore, B. R. Chaitman, M. Hodges, H. Mueller, W. J. Rogers, G. L. Knatterud, et al.
Ischemic Cerebral Infarction After rt-PA and Heparin Therapy for Acute Myocardial Infarction : The TIMI-II Pilot and Randomized Clinical Trial Combined Experience
Stroke, June 1, 1997; 28(6): 1107 - 1114.
[Abstract] [Full Text]


Home page
CirculationHome page
J. M. Gore, C. B. Granger, M. L. Simoons, M. A. Sloan, W. D. Weaver, H. D. White, G. I. Barbash, F. Van de Werf, P. E. Aylward, E. J. Topol, et al.
Stroke After Thrombolysis : Mortality and Functional Outcomes in the GUSTO-I Trial
Circulation, November 15, 1995; 92(10): 2811 - 2818.
[Abstract] [Full Text]


Home page
Med Decis MakingHome page
J. Kellett and J. Clarke
Comparison of "Accelerated" Tissue Plasminogen Activator with Streptokinase for Treatment of Suspected Myocardial Infarction
Med Decis Making, October 1, 1995; 15(4): 297 - 310.
[Abstract] [PDF]